Neo-Synephrine Maximum

Neo-Synephrine Maximum is an FDA drug label for the active ingredient PHENYLEPHRINE HYDROCHLORIDE manufactured by BF ASCHER AND CO INC administered by NASAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231116.

Generic: PHENYLEPHRINE HYDROCHLORIDE

Manufacturer: BF ASCHER AND CO INC

Product Type: HUMAN OTC DRUG

Route: NASAL

Dosage Form:

NDC: 0225-0810

Application: M012

Effective: 20231116

Active Ingredients: Phenylephrine hydrochloride 1.0%

Indications & Usage

Temporarily relieves nasal congestion due to: common cold hay fever upper respiratory allergies Temporarily relieves sinus congestion and pressure Shrinks swollen membranes so you can breathe more freely Temporarily restores freer breathing through the nose.

Dosage & Administration

to spray, squeeze bottle quickly and firmly adults and children 12 years of age and older: 2 or 3 sprays in each nostril not more often then every 4 hours Children under 12 years of age: ask a doctor

Contraindications

Not available.

Warnings

When using this product: temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur. use of this container by more than one person may spread infection. use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.

Adverse Reactions

Not available.

More from same ingredient

Neo-Synephrine Mild

BF ASCHER AND CO INC

Neo-Synephrine Regular

BF ASCHER AND CO INC

PHENYLEPHRINE HYDROCHLORIDE

Meitheal Pharmaceuticals Inc.

PHENYLEPHRINE HYDROCHLORIDE

Somerset Therapeutics, LLC

PHENYLEPHRINE HYDROCHLORIDE

Novadoz Pharmaceuticals LLC